Department of Obstetrics and Gynecology - Faculty of Medicine - Menoufia University
Shibīn al Kawm, EL Menofia, 32651, Egypt
NCT Number: NCT03114332
A randomized controlled trial that aimed at studying the values (if any) of subcutaneous drains use in lean women during Cesarean section.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Shibīn al Kawm, EL Menofia, 32651, Egypt
Cesarean section (CS) is one of the most common operative procedures performed in modern obstetrics. Despite being that, common, surgical techniques and steps do widely vary. These variations depend on many factors including surgeons preferences, patient s characteristics and available facilities and circumstances .
The most common complications of Cesarean section are superficial surgical site complications including sepsis, seroma formation and breakdown.
One of the common, yet debatable, practices in Cesarean section is to use a subcutaneous drain for the wound .The advantage of such a practice is to drain any blood or serous fluid that may accumulate in the subcutaneous space, which cause post-operative pain or provide a good medium for microbial growth and infection.
Thus, it is assumed that drains can reduce the burden of surgical site infection. Some surgeons, however, have raised much argument about the value of subcutaneous drains and emerging evidence raised concerns about its effectiveness. Despite this, it is evident that it is still widely used in the clinical practice.
Most randomized controlled trials on this issue, from which we draw the current evidence, were conducted in the developed countries, mainly the United States, with readily available facilities and optimum level of care. This fact raises concerns about how this evidence can be applicable in developing countries with weak health care systems and low level of awareness. In addition, Cesarean section rates are greatly higher in developing countries due to its abuse, which emphasize how the current evidence can't be applicable and in need for further updates .
The current gap between the current practice and lack of evidence has to be filled. In this study, investigators aim at providing answers for this critical issue, thus investigators can ensure women's health and provide the best quality of care following Cesarean section.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In order to control any confounding variables, we will exclude women with an added risk of wound complications. Those will include:
A closed drainage system for the subcutaneous tissue was used (Redivac) through a separate stab wound. Drains were left in place for 24 h or until drainage was less than 50 ml.
Time frame: within 72 hours after the operation
rate of superficial surgical site infection, defined as presence of wound discharge that yielded a positive result on bacteriological culture within 72 hours after the operation
Time frame: up to 6 weeks postoperative
A seroma is a pocket of clear serous fluid that sometimes develops in the body after surgery
Time frame: up to 6 weeks postoperative
superficial wound breakdown (defined as skin and/or subcutaneous dehiscence with intact fascial layer)
Time frame: 24 hours postoperatively
temperature 38 C, 24 hours postoperatively
Time frame: after 24 hours postoperative
through visual analogue scale (VAS); with 0 meaning no pain, and 10 meaning the worst pain
Menoufia University
Other
Subcutaneous Drains In Lean Women Undergoing Cesarean Section, A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07720440
Agnosia, Behavior
Istanbul, Sultangazi, Turkey (Türkiye)
View Trial DetailsNCT07720986
Cesarean Section
Al Mansurah, Dakhalia, Egypt
View Trial DetailsNCT07521592
Cesarean Section, Cortisol
Elâzığ, Lütfen Seçiniz., Turkey (Türkiye)
View Trial DetailsNCT07712510
Blood Loss, Postoperative, Blood Loss, Surgical
Multan, Punjab Province, Pakistan
View Trial Details